9/27/2021  5:05:07 PM Chg. -165.00 Volume Bid5:15:00 PM Ask9/27/2021 Market Capitalization Dividend Y. P/E Ratio
8,410.00HUF -1.92% 310,509
Turnover: 2.62 bill.
-Bid Size: - -Ask Size: - 3134.83 bill.HUF 2.68% 14.94

Business description

Gedeon Richter Plc., headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. The product portfolio of Richter covers almost all important therapeutic areas, including gynaecology, central nervous system, and cardiovascular areas. Having the largest R&D unit in Central Eastern Europe, Richter's original research activity focuses on CNS disorders. With its widely acknowledged steroid chemistry expertise, Richter is a significant player in the female healthcare field worldwide. Richter is also active in biosimilar product development.
 

Management board & Supervisory board

CEO
Gábor Orbán
Management board
Dr. Gábor Gulácsi, Dr. György Thaler, Dr. Istvan Greiner, Erik Bogsch, Tibor Horváth
Supervisory board
Erik Bogsch, Anett Pandurics, Bálint Szécsényi, Csaba Lantos, Dr. Gábor Gulácsi, Dr. György Bagdy, Dr. Ilona Hardy, Dr. László Szabó, Dr. Nándor Pál Ács, Dr. Péter Cserháti, Gábor Orbán, Prof. Dr. Szilveszter E. Vizi
 

Company data

Name: Gedeon Richter Plc.
Address: Gyömroi út 19-21.,HU-1103 Budapest
Phone: +36-1-431-4000
Fax: +36-1-260-6650
E-mail: -
Internet: www.richter.hu/en/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 84.70%
IPO date: 10/9/1994

Investor relations

Name: -
IR phone: +36-1-431-5764
IR Fax: -
IR e-mail: investor.relations@richter.hu

Company calendar

CW 46 | 11/8/2021 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
84.70%
Maecenas Universitatis Corvini Foundation
 
10.03%
MNV Zrt.
 
5.27%